Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer

What this episode covers

For the complete activity, including supporting material, please visit https://www.peervoice.com/UGY860. Presented by Trisha Wise-Draper, MD, PhD; Christine H. Chung, MD; Renata Ferrarotto, MD; and Kevin Harrington, PhD, FRCP, FRCR. Learning Objectives: Explain the implications of human papillomavirus (HPV) status in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) for patient outcomes and quality of life; Interpret clinical trial data stratified by HPV status to identify limitations of current standard-of-care therapies for non-HPV–associated recurrent/metastatic HNSCC; Explain how tumor microenvironment factors influence treatment resistance and differential outcomes in non-HPV–associated vs HPV-positive oropharyngeal cancer (OPC); Evaluate investigational therapies for non-HPV–associated recurrent/metastatic HNSCC and assess their potential to address unmet clinical needs.

Distinct summary based on available episode metadata or transcript content.